Cardinal buys up Alaris shares:
This article was originally published in Clinica
Cardinal Health has completed its tender offer for all outstanding shares of common stock of Alaris Medical Systems. As previously announced, Cardinal purchased the shares at a price of $22.35 each in cash as part of its plan to acquire San Diego, California-based Alaris. The final steps to completing the merger - in which the developer of needle-free valves and systems will become a wholly-owned Cardinal subsidiary - is going ahead despite the dark cloud of litigation hanging over Alaris. At the end of last month, ICU Medical had filed a patent lawsuit against San Diego, California-based Alaris concerning the latter's SmartSite and SmartSite Plus needle-free valves and systems (see Clinica No 1113, p 12).
You may also be interested in...
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.